While the extent of NfL alteration strongly vary across diagnostic entities, clinical stage, and patient subgroups, the magnitude of NfL elevation in patients with MDD, BD, AN, and SUD might reach a 1.2- to 2.5-fold increase. This evidence concerns the gene NEFL and major depressive disorder.